Nutra Pharma Corp Stock Current Valuation
| NPHC Stock | USD 0.0001 0.00 0.00% |
Valuation analysis of Nutra Pharma Corp helps investors to measure Nutra Pharma's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Nutra Pharma's price fluctuation is out of control at this time. Calculation of the real value of Nutra Pharma Corp is based on 3 months time horizon. Increasing Nutra Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Nutra Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nutra Pink Sheet. However, Nutra Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 9.6E-5 | Hype 9.9E-5 | Naive 1.17E-4 |
The real value of Nutra Pink Sheet, also known as its intrinsic value, is the underlying worth of Nutra Pharma Corp Company, which is reflected in its stock price. It is based on Nutra Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Nutra Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Nutra Pharma Corp helps investors to forecast how Nutra pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nutra Pharma more accurately as focusing exclusively on Nutra Pharma's fundamentals will not take into account other important factors: Nutra Pharma Corp Company Current Valuation Analysis
Nutra Pharma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Nutra Pharma Current Valuation | 10.33 M |
Most of Nutra Pharma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nutra Pharma Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Nutra Pharma Corp has a Current Valuation of 10.33 M. This is 99.93% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.94% higher than that of the company.
Nutra Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nutra Pharma's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nutra Pharma could also be used in its relative valuation, which is a method of valuing Nutra Pharma by comparing valuation metrics of similar companies.Nutra Pharma is currently under evaluation in current valuation category among its peers.
Nutra Fundamentals
| Return On Asset | -1.13 | |||
| Profit Margin | 28.71 % | |||
| Operating Margin | (5.58) % | |||
| Current Valuation | 10.33 M | |||
| Shares Outstanding | 7.6 B | |||
| Shares Owned By Insiders | 1.02 % | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Sales | 6.13 X | |||
| Revenue | 51.9 K | |||
| Gross Profit | 8.47 K | |||
| EBITDA | (365.66 K) | |||
| Net Income | (769.18 K) | |||
| Cash And Equivalents | 10.45 K | |||
| Total Debt | 517.18 K | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (878.09 K) | |||
| Target Price | 0.53 | |||
| Beta | 0.25 | |||
| Market Capitalization | 759.68 K | |||
| Total Asset | 301.79 K | |||
| Z Score | -2.7 | |||
| Net Asset | 301.79 K |
About Nutra Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nutra Pharma Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nutra Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nutra Pharma Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Nutra Pink Sheet
Nutra Pharma financial ratios help investors to determine whether Nutra Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nutra with respect to the benefits of owning Nutra Pharma security.